oseltamivir has been researched along with arginine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Ganguly, S; Kumar, KS; Veerasamy, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| He, JY; Li, C; Wu, G | 1 |
| Correa-Basurto, J; García-Machorro, J; Gema, LR; Martínez-Ramos, F; Padilla-Martínez, I; Tolentino-Lopez, LE | 1 |
| Dandekar, T; Sarukhanyan, E; Shanmugam, TA | 1 |
1 review(s) available for oseltamivir and arginine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for oseltamivir and arginine
| Article | Year |
|---|---|
Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones.
Topics: Antiviral Agents; Cell Line; Drug Evaluation, Preclinical; Humans; Magnetic Resonance Spectroscopy; Quinazolines; Schiff Bases; Spectrophotometry, Infrared | 2010 |
Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.
Topics: Antiviral Agents; Arginine; Drug Discovery; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Lysine; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Mutation; Oseltamivir | 2014 |
Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.
Topics: Amino Acid Sequence; Antiviral Agents; Arginine; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Models, Molecular; Molecular Sequence Data; Mutation; Neuraminidase; Oseltamivir; Protein Binding; Protein Conformation; Sequence Alignment | 2015 |
In Silico Studies Reveal Peramivir and Zanamivir as an Optimal Drug Treatment Even If H7N9 Avian Type Influenza Virus Acquires Further Resistance.
Topics: Acids, Carbocyclic; Antiviral Agents; Arginine; Benserazide; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H7N9 Subtype; Influenza, Human; Molecular Docking Simulation; Mutation; Neuraminidase; Oseltamivir; Zanamivir | 2022 |